As shown in Figure 3C, CCR5–CCR3 and CCR5–CCR2b chimeras, expressed in Ghost cells carrying human CD4 but not CCR5, showed significantly (p < 0.001) impaired capability to support JRFL infection, achieving less than 50% efficacy of WT CCR5. This evidence concerns the gene CCR5 and infection.